JP2013500997A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500997A5
JP2013500997A5 JP2012523088A JP2012523088A JP2013500997A5 JP 2013500997 A5 JP2013500997 A5 JP 2013500997A5 JP 2012523088 A JP2012523088 A JP 2012523088A JP 2012523088 A JP2012523088 A JP 2012523088A JP 2013500997 A5 JP2013500997 A5 JP 2013500997A5
Authority
JP
Japan
Prior art keywords
methyl
nitro
oxy
oxazine
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012523088A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013500997A (ja
JP5685254B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/043908 external-priority patent/WO2011014776A1/en
Publication of JP2013500997A publication Critical patent/JP2013500997A/ja
Publication of JP2013500997A5 publication Critical patent/JP2013500997A5/ja
Application granted granted Critical
Publication of JP5685254B2 publication Critical patent/JP5685254B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012523088A 2009-07-31 2010-07-30 ニトロイミダゾオキサジンおよびニトロイミダゾオキサゾール・アナログならびにそれらの使用 Expired - Fee Related JP5685254B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23042209P 2009-07-31 2009-07-31
US61/230,422 2009-07-31
PCT/US2010/043908 WO2011014776A1 (en) 2009-07-31 2010-07-30 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses

Publications (3)

Publication Number Publication Date
JP2013500997A JP2013500997A (ja) 2013-01-10
JP2013500997A5 true JP2013500997A5 (enExample) 2013-09-12
JP5685254B2 JP5685254B2 (ja) 2015-03-18

Family

ID=42829983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012523088A Expired - Fee Related JP5685254B2 (ja) 2009-07-31 2010-07-30 ニトロイミダゾオキサジンおよびニトロイミダゾオキサゾール・アナログならびにそれらの使用

Country Status (13)

Country Link
US (1) US8293734B2 (enExample)
EP (1) EP2459570B1 (enExample)
JP (1) JP5685254B2 (enExample)
KR (1) KR101738868B1 (enExample)
CN (1) CN102741259B (enExample)
AU (1) AU2010278779B2 (enExample)
BR (1) BR112012002214B1 (enExample)
CA (1) CA2769263C (enExample)
ES (1) ES2530266T3 (enExample)
NZ (1) NZ598165A (enExample)
RU (1) RU2540860C2 (enExample)
WO (1) WO2011014776A1 (enExample)
ZA (1) ZA201201259B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201012209D0 (en) * 2010-05-31 2010-09-08 Ge Healthcare Ltd In vivo imaging agent
JP5916739B2 (ja) * 2011-04-15 2016-05-11 大塚製薬株式会社 6,7−ジヒドロイミダゾ[2,1−b][1,3]オキサジン化合物
JP2015006994A (ja) * 2011-10-28 2015-01-15 大正製薬株式会社 ジヒドロイミダゾオキサゾール誘導体
KR101918469B1 (ko) * 2012-06-04 2018-11-15 한국화학연구원 바이사이클릭 니트로이미다졸 유도체 또는 이들의 광학이성질체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물
US10301294B2 (en) * 2013-03-13 2019-05-28 The Broad Institute Inc. Compounds for the treatment of tuberculosis
CN104059082B (zh) * 2013-03-21 2016-08-03 苏州迈泰生物技术有限公司 硝基咪唑杂环类化合物及其在制备治疗结核病药物中的应用
KR101564425B1 (ko) 2013-11-26 2015-10-30 한국화학연구원 신규한 바이사이클릭 니트로이미다졸 카바메이트 화합물, 이를 제조하는 방법 및 이를 유효성분으로 함유하는 결핵 질환의 예방 또는 치료용 약제학적 조성물
TWI687409B (zh) 2014-08-28 2020-03-11 日商大塚製藥股份有限公司 稠合雜環化合物
KR101682356B1 (ko) 2014-11-04 2016-12-06 한국화학연구원 이미다조 옥사진 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학이성질체 및 이를 유효성분으로 함유하는 약제학적 조성물
WO2016119706A1 (zh) 2015-01-29 2016-08-04 南京明德新药研发股份有限公司 抗肺结核病的硝基咪唑衍生物
GB201519054D0 (en) * 2015-10-28 2015-12-09 Univ Dundee Composition
JP6905506B2 (ja) 2016-02-26 2021-07-21 大塚製薬株式会社 ピペリジン誘導体
CN108727406B (zh) 2017-03-28 2021-12-07 北京协和制药二厂 含氮杂环取代的苯并噁嗪噁唑烷酮类化合物及其制备方法和用途
WO2020223267A1 (en) * 2019-05-01 2020-11-05 Boehringer Ingelheim International Gmbh (r)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate
KR20240122521A (ko) 2021-12-14 2024-08-12 베링거 인겔하임 인터내셔날 게엠베하 만성 신장 질환 치료용 알도스테론 신타아제 억제제
CN114249747A (zh) * 2021-12-27 2022-03-29 苏州虞美景盛新药开发有限公司 一种用于治疗广泛耐药性结核病的硝基咪唑吡喃类药物的新合成工艺

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL41744A0 (en) 1972-03-16 1973-05-31 Ciba Geigy Ag New aryl ether derivatives,their production and their use as pesticides
CH568715A5 (enExample) 1972-03-16 1975-11-14 Ciba Geigy Ag
FR2575158B1 (fr) 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
SU1271861A1 (ru) * 1985-05-07 1986-11-23 Иркутский институт органической химии СО АН СССР Способ получени 2,2-диметил-3-цианометилиденбензимидазо @ 2,1- @ -1,3-оксазолидина
US5668127A (en) * 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
US6087358A (en) 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
AR041198A1 (es) * 2002-10-11 2005-05-04 Otsuka Pharma Co Ltd Compuesto 2,3-dihidro-6-nitroimidazo[2,1-b] oxaxol, y composiciones farmaceuticas que lo contienen
CA2539335A1 (en) * 2003-10-31 2005-05-12 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis
JP4787529B2 (ja) 2004-04-09 2011-10-05 大塚製薬株式会社 医薬組成物
JP4789966B2 (ja) 2004-04-09 2011-10-12 大塚製薬株式会社 医薬組成物
EP1650211B1 (en) 2004-09-17 2011-09-14 Daiso Co., Ltd. Process for preparing imidazopyran derivatives
ATE529430T1 (de) * 2005-07-28 2011-11-15 Vertex Pharma Caspase-hemmer-propharmaka
KR20080079280A (ko) 2005-12-23 2008-08-29 노파르티스 아게 니트로이미다졸 화합물
US20070213341A1 (en) 2006-03-13 2007-09-13 Li Chen Spiroindolinone derivatives
WO2008008480A2 (en) 2006-07-12 2008-01-17 Cumbre Pharmaceuticals Inc. Nitroheteroaryl-containing rifamycin derivatives
NZ579431A (en) 2007-03-09 2012-04-27 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
US7666864B2 (en) 2008-03-26 2010-02-23 Global Alliance For Tb Drug Development Bicyclic nitroimidazole-substituted phenyl oxazolidinones

Similar Documents

Publication Publication Date Title
JP2013500997A5 (enExample)
RU2012107180A (ru) Нитроимидазооксазиновые и нитроимидазооксазольные аналоги и их применение
US20230348418A1 (en) Isoindolinone compounds
US9844553B2 (en) Pyrazolopyridyl compounds as aldosterone synthase inhibitors
CN106065009B (zh) 作为丙型肝炎抑制剂的化合物及其在药物中的应用
US9382226B2 (en) Aldosterone synthase inhibitors
RU2686323C2 (ru) Новые соединения и композиции для ингибирования fasn
ES2640482T3 (es) Derivados biaromáticos antibacterianos
TWI749042B (zh) 作為飢餓素o-醯基轉移酶(goat)抑制劑的㗁二唑吡啶衍生物
JP2014513110A5 (enExample)
JP2010536882A5 (enExample)
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
JP2016530299A5 (enExample)
JP2009538897A5 (enExample)
JP2008513516A5 (enExample)
RU2011108281A (ru) Трипиридилкарбоксамидные антагонисты орексиновых рецепторов
EP2909193A1 (en) Phenyl linked quinolinyl modulators of ror-gamma-t
JP2013500996A5 (enExample)
JP2015502951A5 (enExample)
US9567333B2 (en) Triazolopyridyl compounds as aldosterone synthase inhibitors
RU2012107176A (ru) Нитроимидазооксазины и их применения при противотуберкулезной терапии
US20130172311A1 (en) Substituted heterocyclyl benzyl pyrazoles, and use thereof
WO2012142671A1 (en) Aromatic amides and uses thereof
US20160304486A1 (en) Indoline compounds as aldosterone synthase inhibitors
RU2016129189A (ru) Производные 3-(5-хлор-2-оксобензо[d]оксазол-3(2н)-ил)пропановой кислоты в качестве кмо ингибиторов